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microRNAs are short, noncoding RNAs that can regulate hundreds of targets and thus shape the 
expression landscape of a cell. Similar to mRNA, they often exhibit cell type enriched expression and 
serve to reinforce cellular identity. In tissue with high cellular complexity, such as the central nervous 
system (CNS), it is difficult to attribute microRNA changes to a particular cell type. To facilitate 
interpretation of microRNA studies in these tissues, we used previously generated data to develop a 
publicly accessible and user-friendly database to enable exploration of cell type enriched microRNA 
expression. We provide illustrations of how this database can be utilized as a reference as well as 
for hypothesis generation. First, we suggest a putative role for miR-21 in the microglial spinal injury 
response. Second, we highlight data indicating that differential microRNA expression, specifically 
miR-326, may in part explain regional differences in inflammatory cells. Finally, we show that miR-383 
expression is enriched in cortical glutamatergic neurons, suggesting a unique role in these cells. These 
examples illustrate the database’s utility in guiding research towards unstudied regulators in the CNS. 
This novel resource will aid future research into microRNA-based regulatory mechanisms responsible 
for cellular phenotypes within the CNS.
microRNAs (miRNAs) are short, regulatory RNA molecules that become functionally active after being incor-
porated into the RNA-induced silencing complex (RISC), containing Argonaute-21,2. Canonically, miRNA bind 
target mRNA in their 3′ untranslated region via Watson-Crick base pairing to regulate translation by either direct 
translational inhibition or mRNA destabilization3. Because only partial complementarity is required for a miRNA 
to regulate mRNA translation, miRNAs can regulate hundreds of transcripts in a given cell type4. This widespread 
regulation enables miRNAs to profoundly shape the expression landscape and physiology of a cell. Similar to tran-
scription factors, the cell type specific miRNA code can tune which genes are actively expressed in a given cell type5. 
In fact, several groups have demonstrated that ectopic miRNA expression is sufficient to direct and reprogram cell 
identity, including induced pluripotent stem cells and neurons6,7. It is therefore important to know which miRNAs 
are expressed in a given cell type, but this is difficult in a complex tissue such as the central nervous system (CNS).
Previous studies have performed miRNA-ome analyses of the CNS. For example, Bak and colleagues under-
took a large scale analysis of miRNA expression across 13 distinct neuroanatomical regions, but lacked the resolu-
tion to describe miRNA expression on a cell type specific basis within these nervous system tissues8. To enable cell 
type specific resolution analysis of miRNA expression, He et al. developed a tool for genetic expression of a tagged 
Argonaute-2 in mice, characterizing miRNA expression in several neuronal cell types in cortex and cerebellum9. 
However, the field remains hindered by a lack of a thorough cell type specific analysis of miRNA expression across 
the CNS. Additionally, there has yet to be a publicly accessible and user-friendly database describing cell type 
specific miRNA expression within the nervous system.
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To solve this second problem, we pooled data across studies utilizing this Cre-dependent miRNA affinity 
purification technique9 to identify cell type specific miRNAs across major cell types within the mouse CNS. In 
addition to the He study, we previously leveraged this affinity purification technique to identify miRNAs known 
to be important for particular cell types, such as the motor neuron-enriched miR-21810–12. This discovery enabled 
further study of how aberrant miR-218 expression in cell types that do not physiologically express miR-218, such 
as astrocytes, mediates their dysfunction in a disease like amyotrophic lateral sclerosis13. This example illustrates 
how identifying cell type specific expression of even a single microRNA can be the starting point for a productive 
line of experimental investigation.
In this report, we describe the creation of a website (miRNA.wustl.edu) to provide a platform for compar-
ing miRNA expression for various cell types within nervous system tissue using data generated in Hoye et al., 
201714 and He et al., 20129. Similar sources for protein-coding RNA, including the Brain RNA-Seq atlas14, have 
become widespread research tools in considering which cell types may be involved in an observed pheno-
type15. Our resource will assist future hypothesis generation and experimental analyses by informing on specific 
miRNA-mediated regulatory mechanisms in particular nervous system cell types.
Results
We developed the database to allow interactions with the datasets in two ways – a ‘Search by miRNA’ function that 
will provide graphic illustration for expression of a given miRNA and related family members, and a ‘Search by 
Cell Type’ function that will allow the end user to conduct a variety of differential expression contrasts to identify 
miRNAs that may be enriched in a cell type of interest in an unbiased way. Below, we provide several vignettes 
demonstrating the utility of these functions.
‘Search by miRNA’ highlights the potential role of microglial miR-21a-5p in spinal cord injury. 
One common use for databases is to identify cell types of interest in a given phenotype. As a proof of principle, we 
leveraged our database to help generate a novel hypothesis regarding a previously undescribed role for microglial 
miRNA in spinal cord injury. Several groups have identified miR-21 as significantly upregulated after spinal cord 
injury, causing downregulation of targets FasL and PTEN, and its expression is directly related to secondary cell 
death following injury16–18. By in situ hybridization, miR-21 was expressed in neurons after injury but the majority 
of its expression seems to occur in other cell types18. One study demonstrated miR-21 expression in astrocytes 
following injury both promoted glial scar formation and hindered axonal regrowth, underscoring the importance 
of cell types beyond neurons in the miR-21 injury response19. Our database confirms the expression of miR-21 in 
spinal astrocytes but also indicates an even greater expression in spinal microglia, that is consistent with brain-
stem expression (Fig. 1). Therefore, for those interested in the importance of miR-21 after spinal cord injury, our 
database emphasizes that microglia likely play an underappreciated role. Consistent with this, some evidence 
directly points to the neurotoxic effect of microglial FasL and its repression by microglial miR-2120, but this has 
yet to be investigated in the context of spinal cord injury.
‘Search by miRNA’ reveals cell level regional variability in miR-326-3p expression. An addi-
tional use for our database is to compare regional expression of miRNAs, highlighting potential differences in 
development and physiology of cells within distinct locations. miR-326 is an extreme example of a potentially 
important regional difference. Our database identifies miR-326 as an almost exclusively microglial miRNA within 
the brainstem, however miR-326 is largely absent from spinal microglia. Within the spine, miR-326 expression 
is largely restricted to astrocytes (Fig. 2A). miR-326 has been implicated as a pro-inflammatory miRNA in circu-
lating CD4+ T cells21, so this distinction may contribute to differences in immune and inflammatory responses 
within these neuroanatomically distinct structures. For example, in response to a common peroneal nerve injury, 
microglia are activated within the spine, but not the medulla22. Regional differences, such as those in miR-326 
expression, could underlie this differential response. Interestingly, this regional difference is further complicated 
by extension to other nervous system regions. For example, miR-326 is enriched in the cerebellum over Purkinje 
neurons, consistent with previous findings that glial cells express substantially more miR-326 than neurons 
Figure 1. ‘Search by miRNA’ output for miR-21. Expression is consistently enriched in microglial/immune cells 
within nervous system tissues under physiological conditions (n = 3–4 mice; mean ± SEM). The “Claret” colored 
frame indicates that miR-21a-5p is broadly conserved among most vertebrate, usually including zebrafish.
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(Fig. 2B). However, unlike other assayed regions, miR-326 is readily detectable in neocortical neurons, par-
ticularly interneuron subtypes (Fig. 2C). This indicates further regional variability, where miR-326 is expressed 
by more rostral neurons despite the lack of substantial neuronal expression in the brainstem, spinal cord and 
cerebellum.
miR-383-5p expression highlights a potential specific regulatory role in glutamatergic neurons 
in the cortex. Having two datasets included in our resource can provide complementary information. While 
Hoye et al. 2017 informs on neurons compared to glia, He et al. 2012 supplies information on neuronal subtypes. 
This is particularly informative in the case of a miRNA that is enriched in neurons over glia, but its neuronal 
subtype enrichment is less clear. miR-383-5p is an example of one such neuronal miRNA. In both the brainstem 
and spinal cord, miR-383 is enriched in all neurons, as well as motor neurons, compared to glial cells (Fig. 3A). 
miR-383 expression is similarly enriched in Purkinje neurons over the cerebellum as a whole, but this does not 
aid in identifying the particular neuronal subtypes that are responsible for the majority of miR-383 expression 
(Fig. 3B). However, the neocortical dataset reveals that miR-383 is not equally distributed across neuronal sub-
types. miR-383 is particularly expressed by CamKIIa-positive glutamatergic neurons, relative to other neuronal 
subtypes (Fig. 3C). Interestingly, the expression of miR-383 has been tied to several neurodevelopmental and 
neuropsychiatric conditions. This includes Rett syndrome23, fragile X syndrome24, bipolar disorder25 and schiz-
ophrenia26. Further genomic-level analyses have revealed that the miR-383 locus and target genes are associ-
ated with an increased risk for autism spectrum disorder and linked behaviors, such as rumination27,28. These 
studies suggest that alterations in miR-383 levels and its corresponding targets may be detrimental to maintain-
ing the proper function of neurons, particularly excitatory cortical neurons. It is also possible that miR-383 is 
mis-expressed by other neuronal subtypes. If supported by future experimental studies, such aberrant miR-383 
expression could contribute to excitation-inhibition imbalance often associated with neurodevelopmental and 
psychiatric conditions.
‘Search by cell type’ identifies potential novel modulators of spinal motor neuron and immune 
cell function. We provide end-users with the functionality to search miRNA enrichment by cell type. This 
feature enables identification of the most abundant and/or most specifically expressed miRNA within a given 
cell type. For example, Fig. 4A details the top spinal motor neuron miRNA, relative to all other cell types assayed 
Figure 2. (A) ‘Search by miRNA’ output for miR-326-3p in the brainstem and spinal cord. Expression is readily 
detectable exclusively in microglia of the brainstem and astrocytes of the spine (n = 3–4 mice; mean ± SEM). 
(B) ‘Search by miRNA’ output for miR-326-3p in the cerebellum. miR-326-3p is depleted in Purkinje neurons, 
relative to the cerebellum as a whole (n = 2–3 mice; mean ± SEM). (C) ‘Search by miRNA’ output for miR-
326-3p in the neocortex. miR-326-3p is readily detectable in cortical neurons (n = 2–3 mice; mean ± SEM). 
Only the more predominant and conserved 3p strand is displayed. The “Valencia” colored frame indicates that 
miR-326-3p is conserved among most mammals.
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(including pan-neuronal miRNAs). This identifies both miR-218 strands, as well as potentially novel modulators 
of motor neuron function, including miR-544-3p. The loss of motor neuron-enriched miR-544 in whole spinal 
cord lysates has been associated with insults in the form of spinal cord injury29 or amyotrophic lateral sclerosis 
mutation-carrying muscle30, indicating a novel regulatory mechanism underlying motor neuron homeostasis. 
Additionally, Fig. 4B highlights the top 10 enriched miRNAs in spinal microglia as compared to all spinal neu-
rons. This analysis yields miRNAs known to be associated with immune responses, including miR-223-3p31, 
but also novel miRNAs that have not been previously associated with microglial function. Overall, there were a 
number of miRNAs that were significantly expressed above background and relatively enriched in each cell type 
and CNS region (Table 1).
Discussion
In this report, we detail the creation of a publicly accessible and user-friendly website for analyzing cell type 
enriched microRNA expression and demonstrate its utility to several distinct biological scenarios.
The dual ‘Search by miRNA’ and ‘Search by cell type’ functionality will enable end-users to quickly determine 
which neural cells may be associated with a given miRNA-associated phenotype they might observe throughout 
the course of their study. For example, we leveraged our database to identify microglia-enriched miR-21 regu-
lation of FasL as a likely modulator to secondary neuron injury in spinal cord injury models. It can be equally 
informative to know which miRNAs are not expressed by a given physiological cell type. For example, the fact 
that adult astrocytes do not express miR-218, supports the hypothesis that motor neuron-derived miR-218 may 
contribute to the loss of astrocytic EAAT2 seen in amyotrophic lateral sclerosis13. Understanding which cell types 
express a particular miRNA may also guide development of inhibitors for miRNA, for example miR-155 in amyo-
trophic lateral sclerosis32,33.
One limitation of our database is that the data were produced under physiological conditions in healthy, adult 
mice. It will be important to incorporate additional information into the database based on cell type specific 
miRNA expression under a variety of conditions, such as across multiple developmental time points. Additionally, 
we recognize that a more comprehensive miRNA analysis of other cell types in the neocortex and cerebellum, as 
well as a deeper analysis of the brainstem and spinal cord samples, for example by small RNA sequencing, would 
provide additional information. The use of this sequencing technology indeed produced a greater number of 
Figure 3. (A) ‘Search by miRNA’ output for miR-383-5p in the spine and brainstem. Expression is consistently 
and statistically enriched in neuronal cells over glia (n = 3–4 mice; mean ± SEM). (B) ‘Search by miRNA’ output 
for miR-383-5p in the cerebellum. Expression is enriched in Purkinje neurons, relative to the cerebellum as a 
whole (n = 2–3 mice; mean ± SEM). (C) ‘Search by miRNA’ output for miR-383-5p in the neocortex. Expression 
is highly expressed across neuronal subtypes but is most highly expressed by CamKIIa-positive glutamatergic 
neurons (n = 2–3 mice; mean ± SEM). Only the more predominant and conserved 5p strand is displayed. The 
“Claret” colored frame indicates that miR-383-5p is broadly conserved among most vertebrates.
5Scientific RepoRtS |         (2020) 10:4921  | https://doi.org/10.1038/s41598-020-61307-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
enriched miRNAs per cell type in the He data over the microarray approach utilized by the Hoye data, perhaps 
due to the increased sensitivity to detect less abundant miRNA.
The database is set up such that it can easily accommodate the incorporation of additional cell-specific miRNA 
information. While the database is presently limited to the central nervous system, this strategy can be applied to 
any tissue with characterized Cre driver lines. For example, we have previously utilized this miRNA-tagging and 
affinity purification technique to characterize differences between CD11c+ dendritic cells of the spleen and CNS 
infiltrates during experimental autoimmune encephalitis34.
Existing miRNA tools are useful for target prediction, but fail to provide context as to whether a given 
miRNA and its putative target mRNA are co-expressed in the same cell type. By pairing this database with cur-
rent resources for mRNA expression, future studies can uncover novel cell type specific gene regulatory patterns 
and if these patterns are pathologically disrupted. This database adds to the existing body of resources available 
for studying miRNAs, including target prediction software and broadens the wealth of information available to 
researchers studying miRNA regulation.
Methods
Animals. More details concerning the animals used in the generation of this database can be found in Hoye 
et al. 201710 and He et al. 20129. For Hoye et al. 2017, tissue was harvested from n = 3–4 per group at P63. For 
He et al. 2012, tissue was harvested from n = 2–3 animals per group at P56. All animals were maintained on a 
C57BL/6 background. The following Cre lines were crossed to the loxP-STOP-loxP-GFP-myc-Ago2 line: Syn (all 
Figure 4. (A) Top 10 miRNAs of spinal motor neurons compared to all other cell types. miRNAs were selected 
and sorted by pSI value. (B) Top 10 microglial miRNAs as compared to all neurons in the spine, sorted by 
Log2FC.
Brainstem Spinal Cord Neocortex Cerebellum
All neurons 19 21 — —
Motor neurons 52 60 — —
Astrocytes 54 63 — —
Microglia 59 57 — —
Interneurons — — 102 —
Glutamatergic neurons — — 90 —
PV + interneurons — — 115 —
SOM + interneurons — — 152 —
Purkinje neurons — — — 155
Table 1. Number of detectable miRNAs statistically enriched in each assayed population relative to tissue level 
expression.
6Scientific RepoRtS |         (2020) 10:4921  | https://doi.org/10.1038/s41598-020-61307-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
neurons), ChAT (motor neurons), GFAP (astrocytes), Lyz2 (microglia), Gad2 (interneurons), CamKIIa (gluta-
matergic neurons), Pv (parvalbumin-positive interneurons), SST (somatostatin-positive interneurons) and L7 
(Purkinje neurons of the cerebellum).
Data collection and analysis. The data used to generate this online database were taken from Hoye et al. 
201710 and He et al. 20129, where a more detailed description of the data generation method can be found. Briefly, 
cell type specific miRNAs within the mouse brainstem (pons and medulla), whole spinal cord, neocortex and 
cerebellum were identified using a Cre-dependent miRNA affinity purification technique using cell type specific 
expression of a GFP-tagged Ago2, followed by anti-myc capture. In Hoye et al. 2017, the bound miRNA samples 
were analyzed by microarray. Ct (cycle threshold) counts were LoessM normalized35 for each as a measure of the 
miRNA expression in each cell type. In He et al. 2012, the bound miRNA samples were analyzed by small RNA 
sequencing. The resulting counts, renormalized to library size (as counts per million – CPM) were used here. For 
each tissue, an Ago2 affinity purification was performed to obtain a tissue-wide miRNA profile. In Hoye et al. 
2017, identical myc immunoprecipitation experiments were performed in non-transgenic animals to determine 
background miRNA expression associated with the immunoprecipitation. The relative expression data, log2 fold 
changes between any two given cell types and the associated adjusted p-values, were generated for all pairwise 
comparisons between cell types in each tissue. The specificity index (pSI) value for each miRNA in each cell type is 
used to define its enrichment in the corresponding cell type as compared to all other cell types and total tissue36. pSI 
cutoffs can be varied to define very stringent enrichment (e.g. 10E-5), or moderate enrichment (<0.05). A miRNA 
was considered detectable in the brainstem and spinal cord if its average Ct ≤ 35 and if 2 of 3 biological replicates 
exceeded the median background Ct. For the neocortex and cerebellum, where immunoprecipitation background 
data was not available, a miRNA was considered detectable if its CPM ≥ 1 in at least two biological replicates.
Database creation. The CNS microRNA profiles website was built with Django framework version 1.11 
(https://www.djangoproject.com/weblog/2009/), using Python 3.6, SQLite database, and is deployed using mod_
wsgi-express (https://github.com/GrahamDumpleton/mod_wsgi).
Search by miRNA. The ‘Search by miRNA’ functionality allows a user to visualize the relative expression of a 
miRNA in the cell types within the brainstem, spinal cord, neocortex and cerebellum. Upon entering a miRNA 
name, the webpage will display a list of expression bar plots for the query miRNA and other miRNAs belonging to 
the same group. The top color frame contains the expression plots of the query miRNA in the available tissues. If the 
miRNA is not available in neocortex and cerebellum, the color frame will only contains its expression plots in 
brainstem and spinal cord, and vice versa. The expression plots in brainstem and spinal cord show the relative fold 
changes of the query miRNA in four cell types in brainstem and spinal cord, respectively. Within each bar graph, 
miRNA expression is normalized to all neurons ( =baseline mean Ct of all neurons), the relative fold change of 
which is set to 1.0. All other cell types are displayed as expression relative to all neurons ( −2 )baseline mean Ct . Mean Ct 
of each cell type, as a more direct measure of abundance, is shown beneath the cell type names on the x-axis. For 
RNAseq-based data, the y-axis instead represents log CPM. A second y-axis was added on the right side with the 
corresponding non-log CPM values shown. The error bars show the standard error of the mean. If the miRNA is 
not detectable in a cell type, an “ND” marker in red will be displayed. As the data for this database was generated in 
mice, we included conservation information for potential extension to human systems and because the more con-
served miRNA are likely to be more predominantly expressed. This information is conveyed on the webpage via a 
colored frame around the miRNA of interest that represents its level of conservation. The conservation data was 
drawn from the TargetScan37 “miR Family” data table (http://www.targetscan.org/mmu_72/mmu_72_data_down-
load/miR_Family_Info.txt.zip). Any figure can be downloaded as PDF or PNG images for use with attribution.
Search by cell type. The ‘Search by cell type’ functionality allows a user to find miRNAs that are enriched in 
one cell type (cell type 1) compared to another cell type or all other cell types (cell type 2), in any one of the four 
tissues: brainstem, spinal cord, neocortex and cerebellum. After specifying the tissue type, cell type 1, cell type 
2, sorting method, and number of top enriched miRNAs, the webpage will display a data table showing the top 
enriched miRNAs in cell type 1 relative to cell type 2, and its corresponding Ct / CPM value in each cell type. The 
miRNAs will be sorted by log2 fold change in descending order or p-value in ascending order, if directly compar-
ing two cell types. The miRNAs will be sorted by pSI in ascending order, if comparing one cell type to all other cell 
types. The results table can be downloaded as a CSV data file, PDF, or Excel spreadsheet.
Data availability
An Excel spreadsheet containing the raw data from each dataset can be downloaded from the “Download Data” 
page on the website.
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